4BYI image
Entry Detail
PDB ID:
4BYI
Keywords:
Title:
Aurora A kinase bound to a highly selective imidazopyridine inhibitor
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-07-19
Release Date:
2013-11-20
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:AURORA KINASE A
Chain IDs:A
Chain Length:285
Number of Molecules:1
Biological Source:HOMO SAPIENS
Ligand Molecules
Primary Citation
Aurora Isoform Selectivity: Design and Synthesis of Imidazo[4,5-B]Pyridine Derivatives as Highly Selective Inhibitors of Aurora-A Kinase in Cells.
J.Med.Chem. 56 9122 ? (2013)
PMID: 24195668 DOI: 10.1021/JM401115G

Abstact

Aurora-A differs from Aurora-B/C at three positions in the ATP-binding pocket (L215, T217, and R220). Exploiting these differences, crystal structures of ligand-Aurora protein interactions formed the basis of a design principle for imidazo[4,5-b]pyridine-derived Aurora-A-selective inhibitors. Guided by a computational modeling approach, appropriate C7-imidazo[4,5-b]pyridine derivatization led to the discovery of highly selective inhibitors, such as compound 28c, of Aurora-A over Aurora-B. In HCT116 human colon carcinoma cells, 28c and 40f inhibited the Aurora-A L215R and R220K mutants with IC50 values similar to those seen for the Aurora-A wild type. However, the Aurora-A T217E mutant was significantly less sensitive to inhibition by 28c and 40f compared to the Aurora-A wild type, suggesting that the T217 residue plays a critical role in governing the observed isoform selectivity for Aurora-A inhibition. These compounds are useful small-molecule chemical tools to further explore the function of Aurora-A in cells.

Legend

Protein

Chemical

Disease

Primary Citation of related structures